COVID-19: We weren’t careless, expired vaccines had very short expiration date — NAFDAC DG
Dec. 29, 2021 Prof. Mojisola Adeyeye, Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), says the agency is working with international partners to ensure Nigeria gets…
AstraZeneca vaccine booster works against Omicron, Oxford lab study finds
Dec. 23, 2021 A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University…
Up to 1 million COVID vaccines expired in Nigeria last month
Dec. 8, 2021 Up to one million COVID-19 vaccines are estimated to have expired in Nigeria last month without being used, two sources told Reuters, one of the biggest single…
COVID-19: Push for intellectual property waivers to begin reproduction of existing vaccines – AfDB tells African nations
Dec. 7, 2021 The African development Bank (AfDB) has tasked African nations to immediately commence the production of COVID-19 Vaccines as a move towards attaining herd immunity and creating jobs….
Officials offer vaccine reassurance as WHO advises against travel bans
Dec. 1, 2021 The World Health Organization warned countries on Tuesday not to impose blanket travel bans over the new Omicron coronavirus variant as governments and scientists try to determine…
Logistical challenges hamper COVID-19 vaccination drives in Africa
Nov 26, 2021 …Only 6.6% of Africa’s population fully vaccinated Many African nations are struggling with the logistics of accelerating their COVID-19 inoculation campaigns as deliveries of vaccines to the…
AstraZeneca’s preventative COVID-19 shot shown to work longer-term
Nov 18, 2021 AstraZeneca on Thursday cemented its lead in bringing a preventative COVID-19 shot for the non-infected to market for people who do not respond well to vaccines, saying…
COVID vaccines not linked to menstrual changes, goes together with flu shots
Nov. 16, 2021 The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to…
AstraZeneca to set up division for vaccines, antibody therapies
Nov. 10, 2021 AstraZeneca is creating a separate division for vaccines and antibody therapies, the drugmaker said on Tuesday, to focus on its COVID-19 shot and coronavirus treatments after a…
AstraZeneca to transfer some drug rights to Covis Pharma in $270m deal
Nov. 1, 2021 AstraZeneca said on Monday it will transfer global rights for respiratory medicines Eklira and Duaklir to Covis Pharma Group for $270 million, as the Anglo-Swedish drugmaker looks…